Report cover image

Global Healthcare Visual Inspection Services Market Size Study, By Product (Pharmaceutical, Medical Device), By Technology (Manual Visual Inspection, Semi-automated Visual Inspection, Automated Visual Inspection), By End-use (Pharmaceutical & Biopharmaceu

Publisher Factview Research
Published Oct 03, 2025
Length 285 Pages
SKU # FAVR20464148

Description

The Global Healthcare Visual Inspection Services Market is valued at approximately USD 4.01 billion in 2024 and is projected to grow at a CAGR of 10.5% over the forecast period from 2024 to 2034. The market's growth is primarily driven by increasing regulatory requirements for quality assurance in pharmaceuticals and medical devices, technological advancements in AI-powered machine vision and deep learning algorithms, and the growing trend of outsourcing visual inspection services to Contract Development and Manufacturing Organizations (CDMOs), Contract Research Organizations (CROs), and Contract Manufacturing Organizations (CMOs).

The demand for automated and semi-automated visual inspection solutions has risen significantly, enabling enhanced defect detection, minimizing human error, and ensuring product consistency. The pharmaceutical segment, which accounted for 65.15% of market share in 2024, is benefiting from stringent GMP compliance, increasing chronic disease prevalence, and the rise in drug development activities. The medical device sector, which is projected to witness the highest CAGR over the forecast period, is leveraging automated visual inspection (AVI) to ensure compliance with FDA, EMA, and MHRA standards while reducing contamination risks and ensuring the safety of critical medical devices.

Technological advancements, including 3D vision systems, AI-powered cloud analytics, and real-time imaging, are enhancing micro-defect detection capabilities in both pharmaceutical and medical device manufacturing. Additionally, regulatory agencies worldwide, such as the FDA, EMA, and MHRA, have reinforced the adoption of automated and semi-automated inspection techniques to enhance quality control and reduce variability in parenteral drugs, biologics, and sterile injectables. This regulatory push is leading to an increase in strategic partnerships, M&As, and global facility expansions by industry players to cater to growing market demand.

Regional Analysis- The North American healthcare visual inspection services market dominated the industry in 2024, accounting for 40.68% of revenue share, driven by the presence of major pharmaceutical and medical device manufacturers, stringent regulatory frameworks, and high adoption of automated inspection solutions. The European market is witnessing steady growth, fueled by an emphasis on quality control, drug innovation, and increasing regulatory scrutiny.

The Asia-Pacific region is expected to witness the fastest CAGR over the forecast period, supported by the expansion of pharmaceutical and medical device manufacturing, government initiatives to enhance quality control standards, and rising investment in outsourcing services. China, Japan, and India are emerging as key markets due to their growing contract manufacturing industry, strong export demand, and government-backed initiatives for stringent product quality standards.

Major Market Players Included in This Report
  • Charles River Laboratories
  • Jabil Inc.
  • Lonza Group
  • Grand River Aseptic Manufacturing
  • Vetter Pharma
  • NIVAGEN
  • Recipharm AB
  • Samsung Biologics
  • SGS SA
  • West Pharmaceutical Services, Inc.
  • Adragos Pharma
  • Catalent, Inc.
The Detailed Segments and Sub-segments of the Market Are Explained Below:

By Product:
  • Pharmaceutical
  • Medical Device
By Technology:
  • Manual Visual Inspection (MVI)
  • Semi-Automated Visual Inspection (SAVI)
  • Automated Visual Inspection (AVI)
By End-use:
  • Pharmaceutical & Biopharmaceutical Companies
  • Medical Device Companies
  • Others
By Region:

North America
  • U.S.
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Rest of Europe
Asia-Pacific
  • Japan
  • China
  • India
  • Thailand
  • South Korea
  • Australia
  • Rest of Asia-Pacific
Latin America
  • Brazil
  • Argentina
  • Rest of Latin America
Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Kuwait
  • Rest of Middle East & Africa
Years considered for the study:
  • Historical Year: 2022
  • Base Year: 2024
  • Forecast Period: 2025-2034
Key Takeaways:
  • Market Estimates & Forecast for 10 years from 2022 to 2034.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed geographical landscape with country-level analysis of major regions.
  • Competitive landscape analysis, including key players' strategies and SWOT analysis.
  • Evaluation of technological advancements and innovations shaping the market.
  • Analysis of market challenges, drivers, and opportunities influencing industry growth.
  • Strategic recommendations for key industry stakeholders

Table of Contents

285 Pages
Chapter 1. Global Healthcare Visual Inspection Services Market Executive Summary
1.1. Global Healthcare Visual Inspection Services Market Size & Forecast (2024-2034)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Technology
1.3.3. By End-use
1.4. Key Trends
1.5. Recession Impact
1.6. Industry Metrics
1.7. Investment Analysis
1.8 .Investment Rationale
1.9. Analyst Recommendation & Conclusion
Chapter 2. Global Healthcare Visual Inspection Services Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Healthcare Visual Inspection Services Market Dynamics
3.1. Market Drivers
3.1.1. Increasing GMP & Regulatory Compliance
3.1.2. Growth in Pharmaceutical & Medical Device Outsourcing
3.1.3. Technological Advancements in AI-powered Inspection Systems
3.2. Market Challenges
3.2.1. High Cost of Advanced Automated Systems
3.2.2. Stringent Regulatory Hurdles for New Technologies
3.3. Market Opportunities
3.3.1. Expansion in Emerging Markets
3.3.2. AI & Machine Learning Integration
Chapter 4. Global Healthcare Visual Inspection Services Market Industry Analysis
4.1. Porter’s 5 Forces Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Healthcare Visual Inspection Services Market Size & Forecasts by Product (2024-2034)
5.1. Segment Dashboard
5.2. Global Healthcare Visual Inspection Services Market Revenue by Product (USD Million), 2022 & 2032
5.2.1. Pharmaceutical
5.2.2. Medical Device
Chapter 6. Global Healthcare Visual Inspection Services Market Size & Forecasts by Technology (2024-2034)
6.1. Segment Dashboard
6.2. Global Healthcare Visual Inspection Services Market Revenue by Technology (USD Million), 2022 & 2032
6.2.1. Manual Visual Inspection (MVI)
6.2.2. Semi-Automated Visual Inspection (SAVI)
6.2.3. Automated Visual Inspection (AVI)
Chapter 7. Global Healthcare Visual Inspection Services Market Size & Forecasts by End-use (2024-2034)
7.1. Segment Dashboard
7.2. Global Healthcare Visual Inspection Services Market Revenue by End-use (USD Million), 2022 & 2032
7.2.1. Pharmaceutical & Biopharmaceutical Companies
7.2.2. Medical Device Companies
7.2.3. Others
Chapter 8. Global Healthcare Visual Inspection Services Market Size & Forecasts by Region (2024-2034)
8.1. North America Healthcare Visual Inspection Services Market
8.1.1. U.S.
8.1.2. Canada
8.1.3. Mexico
8.2. Europe Healthcare Visual Inspection Services Market
8.2.1. U.K.
8.2.2. Germany
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Denmark
8.2.7. Sweden
8.2.8. Norway
8.2.9. Rest of Europe
8.3. Asia-Pacific Healthcare Visual Inspection Services Market
8.3.1. Japan
8.3.2. China
8.3.3. India
8.3.4. Thailand
8.3.5. South Korea
8.3.6. Australia
8.3.7. Rest of Asia-Pacific
8.4. Latin America Healthcare Visual Inspection Services Market
8.4.1. Brazil
8.4.2. Argentina
8.4.3. Rest of Latin America
8.5. Middle East & Africa Healthcare Visual Inspection Services Market
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. South Africa
8.5.4. Kuwait
8.5.5. Rest of Middle East & Africa
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Charles River Laboratories
9.1.2. Lonza Group
9.1.3. Samsung Biologics
9.2. Top Market Strategies
9.3. Company Profiles
Chapter 10. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us